COVID-19 Research Paper Volume 13, Issue 13 pp 16904—16921

Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2

Survival curves in BC patients with higher and lower ATP6AP1 levels. (A, B) OS and RFS of BC patients from the Kaplan-Meier plotter database (n = 1089 and n = 947, respectively). (C, D) OS and DFS curves of BC patients from GEPIA (n = 1070 and n = 1070, respectively).

Figure 2. Survival curves in BC patients with higher and lower ATP6AP1 levels. (A, B) OS and RFS of BC patients from the Kaplan-Meier plotter database (n = 1089 and n = 947, respectively). (C, D) OS and DFS curves of BC patients from GEPIA (n = 1070 and n = 1070, respectively).